These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Contact allergy to special and standard allergens in patients with venous ulcers. Tomljanović-Veselski M; Lipozencić J; Lugović L Coll Antropol; 2007 Sep; 31(3):751-6. PubMed ID: 18041384 [TBL] [Abstract][Full Text] [Related]
44. Corticosteroid cross-reactivity. Isaksson M; Bruze M Contact Dermatitis; 2003 Jul; 49(1):53-4. PubMed ID: 14641133 [No Abstract] [Full Text] [Related]
45. Corticosteroid contact allergy--the importance of late readings and testing with corticosteroids used by the patients. Isaksson M Contact Dermatitis; 2007 Jan; 56(1):56-7. PubMed ID: 17177720 [No Abstract] [Full Text] [Related]
46. Contact allergy to prednicarbate: frequency of positive reactions in consecutively-patch-tested patients. Stingeni L; Lisi P Contact Dermatitis; 1999 May; 40(5):286-7. PubMed ID: 10344492 [No Abstract] [Full Text] [Related]
47. Allergic contact dermatitis from tixocortol pivalate in a nasal spray masquerading as infectious complication of sinusitis. Bircher AJ; Hirsbrunner P; Tschopp K; Wildermuth V ORL J Otorhinolaryngol Relat Spec; 1995; 57(1):54-6. PubMed ID: 7700614 [TBL] [Abstract][Full Text] [Related]
48. Contact hypersensitivity to corticosteroids in routine patch test patients. A multi-centre study of the Swiss Contact Dermatitis Research Group. Bircher AJ; Thürlimann W; Hunziker T; Pasche-Koo F; Hunziker N; Perrenoud D; Elsner P; Schultheiss R Dermatology; 1995; 191(2):109-14. PubMed ID: 8520055 [TBL] [Abstract][Full Text] [Related]
50. Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study. Mercader-García P; Pastor-Nieto MA; García-Doval I; Giménez-Arnau A; González-Pérez R; Fernández-Redondo V; Serra-Baldrich E; Cordoba-Guijarro S; Gatica-Ortega ME; Silvestre-Salvador JF; Contact Dermatitis; 2018 Jan; 78(1):76-82. PubMed ID: 28960334 [TBL] [Abstract][Full Text] [Related]
51. Contact allergy to budesonide and perforation of the nasal septum. Isaksson M; Bruze M; Wihl JA Contact Dermatitis; 1997 Sep; 37(3):133. PubMed ID: 9330826 [No Abstract] [Full Text] [Related]
52. Patch testing with serial dilutions of budesonide, its R and S diastereomers, and potentially cross-reacting substances. Isaksson M; Bruze M; Lepoittevin JP; Goossens A Am J Contact Dermat; 2001 Sep; 12(3):170-6. PubMed ID: 11526524 [TBL] [Abstract][Full Text] [Related]
53. Hydrocortisone sensitivity. An investigation into the nature of the allergen. Wilkinson SM; English JS Contact Dermatitis; 1991 Sep; 25(3):178-81. PubMed ID: 1838313 [TBL] [Abstract][Full Text] [Related]
55. Allergic contact dermatitis to personal care products and topical medications in adults with atopic dermatitis. Rastogi S; Patel KR; Singam V; Silverberg JI J Am Acad Dermatol; 2018 Dec; 79(6):1028-1033.e6. PubMed ID: 30053491 [TBL] [Abstract][Full Text] [Related]
56. Screening for corticosteroid contact sensitivity. Comparison of tixocortol pivalate, hydrocortisone-17-butyrate and hydrocortisone. Lauerma AI Contact Dermatitis; 1991 Feb; 24(2):123-30. PubMed ID: 1828209 [TBL] [Abstract][Full Text] [Related]
57. Characterization of the T cell response in allergic contact dermatitis caused by corticosteroids. Baeck M; Soria A; Marot L; Theate I; Hendrickx E; Van Belle A; Goossens A; Tennstedt D; Dachelet C; Jaeger J; Pilette C; Renauld JC; Van Baren N; Rozières A; Nicolas JF; Dumoutier L Contact Dermatitis; 2013 Jun; 68(6):357-68. PubMed ID: 23692036 [TBL] [Abstract][Full Text] [Related]
58. Contact allergy to topical corticosteroids and systemic allergy to prednisolone. McKenna DB; Murphy GM Contact Dermatitis; 1998 Feb; 38(2):121-2. PubMed ID: 9506238 [No Abstract] [Full Text] [Related]
59. Contact sensitivity to budesonide in a child. Auricchio L; Nino M; Suppa F Contact Dermatitis; 2000 Jun; 42(6):359. PubMed ID: 10871107 [No Abstract] [Full Text] [Related]
60. Patch testing with budesonide in serial dilutions: the significance of dose, occlusion time and reading time. Isaksson M; Bruze M; Goossens A; Lepoittevin JP Contact Dermatitis; 1999 Jan; 40(1):24-31. PubMed ID: 9928801 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]